FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REMIMAZOLAM
异名/同义词4H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPINE-4-PROPANOIC ACID, 8-BROMO-1-METHYL-6-(2-PYRIDINYL)-, METHYL ESTER, (4S)-
4H-IMIDAZOL(1,2-A)(1,4)BENZODIAZEPINE-4-PROPIONIC ACID, (S)-
CNS-7056
METHYL 3-((4S)-8-BROMO-1-METHYL-6-(PYRIDIN-2-YL)-4H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-4-YL)PROPANOATE
ONO-2745
REMIMAZOLAM
REMIMAZOLAM [INN]
REMIMAZOLAM [MI]
REMIMAZOLAM [USAN]
REMIMAZOLAM [WHO-DD]
CAS登记号308242-62-8
物质唯一标识(Unique Ingredient Identifier)7V4A8U16MB
分子式C21H19BrN4O2
国际化合物标识(International Chemical Identifier,InChI)CYHWMBVXXDIZNZ-KRWDZBQOSA-N
SMILESCc1cnc2[C@H](CCC(=O)OC)N=C(c3cc(ccc3-n12)Br)c4ccccn4
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System